CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PCSA

PCS6422 and capecitabine

Phase 2
Processa Pharmaceuticals, Inc. (PCSA)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
PCSAPhase 2

PCS6422 and capecitabine Phase 2 Est. Readout

PCS6422 and capecitabine
Sep 2026~STALE
CT.gov
00%
Drug Information

Target Indication

Breast Cancer

Clinical Trial

NCT06568692

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.